Duodenal‐jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3‐year outcomes in the First National Health Service (NHS) EndoBarrier Service

por Ryder, Robert E. J., Yadagiri, Mahi, Burbridge, Wyn, Irwin, Susan P., Gandhi, Hardeep, Bashir, Tahira, Allden, Rachael A., Wyres, Melanie, Cull, Melissa, Bleasdale, John P., Fogden, Edward N., Anderson, Mark R., Sen Gupta, Piya
Publicado 2022

Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide

por Ryder, Robert E.J., Laubner, Katharina, Benes, Marek, Haluzik, Martin, Munro, Lynne, Frydenberg, Harry, Teare, Julian P., Ruban, Aruchuna, Fishman, Sigal, Santo, Erwin, Stengel, Rainer, De Jonge, Charlotte, Greve, Jan W., Cohen, Ricardo V., Aboud, Cristina M., Holtmann, Gerald J., Rich, Graeme, McMaster, Jess J., Battelino, Tadej, Kotnik, Primoz, Byrne, James P., Mason, John C., Bessell, Justin, Bascomb, Jeanine, Kow, Lillian, Collins, Janes, Chisholm, Jacob, Pferschy, Peter N., Sourij, Harald, Cull, Melissa L., Wyres, Melanie C., Drummond, Russell, McGowan, Barbara, Amiel, Stephanie A., Yadagiri, Mahi, Sen Gupta, Piya, Aberle, Jens, Seufert, Jochen
Publicado 2023